UFPT Stock Cash Flow Statements

UFP Technologies Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

UFP Technologies Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31

cash flows from operating activities:
net income	17,180,000	17,184,000		16,361,000	13,552,000	12,693,000		11,694,000	11,883,000	9,739,000		19,540,000	8,929,000	4,858,000		3,789,000	4,715,000	4,163,000		2,988,000	2,318,000	3,891,000		5,641,000	4,598,000	3,734,000		4,134,000	3,990,000	1,777,000		1,694,000	2,630,000	2,171,000		2,669,000	2,735,000	1,075,000		1,991,000	2,273,000	1,653,000		2,066,000	1,860,000	2,062,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	4,719,000	4,634,000	4,657,000	4,027,000	3,032,000	2,999,000	2,961,000	2,839,000	2,830,000	2,777,000	2,749,000	2,804,000	3,317,000	3,016,000	2,201,000	2,037,000	2,103,000	2,069,000	2,058,000	2,060,000	2,084,000	2,066,000	2,052,000	2,070,000	2,028,000	2,022,000	2,011,000	1,946,000	2,042,000	1,832,000	1,464,000	1,375,000	1,401,000	1,395,000	1,525,000	1,360,000	1,382,000	1,367,000	1,339,000	1,166,000	1,188,000	1,153,000	1,169,000	960,000	1,116,000	1,131,000	1,102,384
(gain) loss on disposal of property, plant & equipment																-22,000
share-based compensation	2,285,000	2,212,000	2,055,000	1,538,000	1,736,000	1,513,000	1,191,000	1,197,000	1,197,000	1,056,000	838,000	897,000	781,000	692,000	657,000	650,000	620,000	501,000	469,000	240,000	561,000	537,000	422,000	473,000	402,000	294,000	249,000	272,000	454,000	237,000	226,000	206,000	427,000	209,000	185,000	229,000	441,000	201,000	196,000	226,000	437,000	210,000	174,000	215,000	465,000	265,000	216,547
change in fair value of contingent consideration	263,000	263,000	238,000	238,000	238,000	238,000	238,000	238,000	198,000	2,853,000	489,000	3,346,000
equity method investment net earnings	-57,000	-41,000
deferred income taxes	263,000	1,443,000	505,000	523,000	-287,000	591,000	342,000	940,000	79,000	-545,000	-5,125,000	798,000	57,000	-440,000	-2,276,000	99,000	104,000	279,000	-841,000	246,000	310,000	421,000	-460,000	415,000	413,000	424,000	874,000	319,000	342,000	346,000	-1,273,000	94,000	82,000	78,000	352,000	0	137,000	87,000	154,000	89,000	98,000	96,000
changes in operating assets and liabilities:
receivables	10,168,000	-8,904,000	4,110,000	-7,123,000	1,110,000	3,120,000	-3,333,000	3,016,000	-3,944,000	-4,863,000	2,977,000	-3,478,000	-11,896,000	-4,467,000	-1,726,000	-1,234,000	-1,204,000	-3,590,000	936,000	-93,000	2,178,000	-801,000	148,000	1,885,000	-909,000	-1,451,000	1,823,000	35,000	-894,000	-3,520,000	663,000	262,000	-383,000	-674,000	1,058,000	713,000	-2,644,000	-2,895,000									774,424
inventories	6,151,000	-2,204,000	947,000	1,716,000	-3,598,000	-3,751,000	-298,000	-6,819,000	-6,394,000	-3,054,000	480,000	-4,873,000	-7,386,000	-7,826,000	-1,464,000	-514,000	-1,144,000	-1,374,000	846,000	1,471,000	-717,000	-1,966,000	943,000	-181,000	399,000	139,000	326,000	-1,170,000	-474,000	-977,000	273,000	959,000	316,000	-260,000	417,000	-684,000	-666,000	984,000
prepaid expenses and other current assets	455,000	-790,000		70,000	-258,000	-752,000		1,772,000	-1,018,000	-377,000		1,438,000	392,000	-1,712,000		-120,000	-327,000	-70,000
other assets	-1,324,000	-2,334,000	1,119,000	-1,441,000	690,000	261,000	302,000	53,000	3,052,000	-1,850,000	-908,000	367,000	-3,312,000	308,000	-753,000	240,000	51,000	-219,000	-149,000	81,000	-252,000	247,000	75,000	213,000	160,000	-338,000	363,000	-191,000	-93,000	-155,000	-90,000	-75,000	-49,000	-14,000	-4,000	-58,000			220,000
accounts payable	-7,613,000	5,284,000	-1,878,000	36,000	-728,000	1,428,000	-5,162,000	1,853,000	4,797,000	65,000	2,797,000	-5,498,000	7,727,000	4,105,000	-3,108,000	-822,000	2,376,000	1,656,000	-426,000	-990,000	-1,991,000	2,726,000	-2,252,000	1,002,000	-315,000	-907,000	-1,136,000	-658,000	3,197,000	-290,000	-336,000	532,000	-1,616,000	1,513,000	-1,104,000	-357,000	1,083,000	-218,000					129,000	1,108,000	-487,000	1,567,000
accrued expenses	-4,151,000	-1,922,000	707,000	1,431,000	3,544,000	-5,597,000	3,384,000	1,925,000	0	-6,197,000	-2,541,000	8,393,000	7,960,000	-3,366,000	589,000	169,000	1,331,000	-1,083,000	-471,000	1,302,000	763,000	-2,133,000	-664,000	659,000	2,536,000	-2,506,000	1,889,000	1,161,000	-133,000	-1,445,000	407,000	727,000	545,000	-614,000	-359,000	603,000	1,402,000	-2,007,000	-1,068,000	296,000
deferred revenue	-199,000	124,000	-1,129,000	1,245,000	25,000	-2,089,000	2,801,000	-450,000	683,000	-1,098,000	507,000	-864,000	572,000	793,000	2,510,000	-232,000	140,000	-124,000	-59,000	-702,000	216,000	-142,000	42,000	-419,000	-21,000	465,000	-1,411,000	587,000	201,000	658,000
income taxes payable	1,353,000	1,801,000		-355,000	-1,799,000	1,401,000		-691,000	-4,235,000	2,765,000				1,130,000				847,000
non-qualified deferred compensation plan and other liabilities	-4,151,000	-2,940,000	-1,125,000	1,535,000	-5,541,000	-1,410,000		465,000	-357,000	451,000		-4,839,000	-1,534,000	-296,000		-273,000	-475,000	279,000	-131,000	448,000	704,000	62,000	648,000	-19,000	-924,000	608,000	-325,000	126,000	52,000	103,000		59,000	22,000	120,000
net cash from operating activities	25,331,000	13,810,000	24,424,000	19,801,000	11,714,000	10,654,000	12,701,000	18,033,000	8,877,000	1,723,000	17,888,000	-109,000	3,181,000	-3,216,000	618,000	3,788,000	6,553,000	3,334,000	8,299,000	6,002,000	5,994,000	4,742,000	8,843,000	10,028,000	8,729,000	3,629,000	7,771,000	6,102,000	9,439,000	-1,992,000	4,459,000	5,084,000	3,788,000	4,138,000	2,814,000	5,001,000	3,986,000	-2,408,000	3,851,000	3,560,000			4,274,000	4,910,000			4,565,600
capex	-2,857,000	-2,817,000	0	-2,146,000	-2,771,000	-1,732,000	0	-2,783,000	-2,772,000	-2,179,000	0	-2,314,000	-6,168,000	-2,334,000	0	-995,000	-1,833,000	-1,449,000	0	-906,000	-1,131,000	-1,020,000	0	-1,562,000	-1,431,000	-1,388,000	0	-1,530,000	-1,497,000	-1,494,000	-3,502,000	-2,409,000	0	-1,463,000	0	-1,717,000	-2,758,000	-1,602,000	0	0			0	0			0
free cash flows	22,474,000	10,993,000	24,424,000	17,655,000	8,943,000	8,922,000	12,701,000	15,250,000	6,105,000	-456,000	17,888,000	-2,423,000	-2,987,000	-5,550,000	618,000	2,793,000	4,720,000	1,885,000	8,299,000	5,096,000	4,863,000	3,722,000	8,843,000	8,466,000	7,298,000	2,241,000	7,771,000	4,572,000	7,942,000	-3,486,000	957,000	2,675,000	3,788,000	2,675,000	2,814,000	3,284,000	1,228,000	-4,010,000	3,851,000	3,560,000			4,274,000	4,910,000			4,565,600
cash flows from investing activities:
additions to property, plant, and equipment	-2,857,000	-2,817,000		-2,146,000	-2,771,000	-1,732,000		-2,783,000	-2,772,000	-2,179,000		-2,314,000	-6,168,000	-2,334,000		-995,000	-1,833,000	-1,449,000		-906,000	-1,131,000	-1,020,000		-1,562,000	-1,431,000	-1,388,000		-1,530,000	-1,497,000	-1,494,000				-1,463,000		-1,717,000	-2,758,000	-1,602,000
acquisitions, net of cash acquired
acquisition working capital adjustments
proceeds from sale of fixed assets			7,000	13,000				-2,000	2,000	2,000		6,705,000	0	12,000		30,000				78,000	14,000	13,000						9,000	28,000	40,000		0	1,000	5,000		0	0	4,000		0	0	31,000
net cash from investing activities	-5,650,000	-2,817,000	-3,884,000	-197,167,000	-7,381,000	-1,732,000	-2,756,000	-2,785,000	-2,770,000	-2,177,000	-2,964,000	33,398,000	-6,168,000	-22,975,000	-97,233,000	-965,000	-1,812,000	-1,449,000	-1,309,000	-828,000	-1,117,000	-1,007,000	-1,393,000	-1,562,000	-1,431,000	-1,388,000	-907,000	-1,521,000	-1,469,000	-78,432,000	-3,501,000	-2,409,000	-3,007,000	-1,458,000	-1,206,000	-1,717,000	-2,758,000	-1,598,000
cash flows from financing activities:
proceeds from advances on revolving line of credit	7,500,000	9,000,000	44,000,000	70,000,000	38,200,000	7,000,000	0	0	3,000,000	6,000,000	0	10,000,000	6,000,000	28,000,000					0	0							0	0	0	36,000,000
payments on revolving line of credit	-23,500,000	-12,500,000	-63,500,000	-18,200,000	-7,000,000	-3,000,000	-10,000,000	-13,000,000			-15,000,000	-38,000,000	0	-7,000,000					0	0			0	-1,000,000	-4,000,000	-3,000,000	-8,000,000	-5,000,000	-9,000,000	-6,000,000
principal payments of long-term debt	-3,125,000	-3,125,000	-3,125,000	0	-30,000,000	-2,000,000		-1,000,000	-1,000,000	-1,000,000		-1,000,000	-1,000,000	-1,000,000
payment of contingent consideration	0	-250,000	0	0			0	0
principal payments on finance lease obligations	-16,000	-16,000	-15,000	-17,000	-21,000	-20,000	-16,000	-15,000	-16,000	-16,000	-16,000	-15,000	-16,000	-16,000
proceeds from the exercise of stock options	58,000	107,000	126,000	0	53,000	54,000				109,000
payment of statutory withholdings for restricted stock units vested	0	-3,914,000		0	0	-4,751,000		0	109,000	-2,522,000		-189,000	-3,000	-1,299,000		0	-2,000	-738,000		0	-1,000	-560,000
net cash from financing activities	-19,083,000	-10,698,000	-22,717,000	176,783,000	1,044,000	-2,717,000	-11,244,000	-14,015,000	-7,336,000	2,571,000	-20,723,000	-28,858,000	5,002,000	18,685,000	74,638,000	-2,000	155,000	-742,000	-191,000	-5,000	55,000	-144,000	-15,097,000	-2,307,000	-4,560,000	-2,986,000	-8,714,000	-5,408,000	-9,119,000	49,510,000	-226,000	57,000	-22,000	-284,000	-367,000	-173,000	320,000	-339,000
effect of foreign currency exchange rates on cash and cash equivalents	266,000	283,000	-729,000	211,000	-21,000	-96,000	186,000	-148,000	17,000	-65,000	313,000	-70,000	-91,000	41,000
net increase in cash and cash equivalents	864,000	578,000		-372,000	5,356,000	6,109,000		1,085,000	-1,212,000	2,052,000		4,361,000	1,924,000	-7,465,000		2,821,000	4,896,000	1,143,000		5,169,000	4,932,000	3,591,000		6,159,000				-827,000	-1,149,000	-30,914,000		2,732,000	759,000	2,396,000
cash and cash equivalents at beginning of period	0	13,450,000		0	0	5,263,000		0	0	4,451,000		0	0	11,117,000		0	0	24,234,000		0	0	3,743,000		0	0	3,238,000		0	0	37,978,000		0	0	31,359,000		0	0	29,804,000		0	0	34,052,000		0	0	37,303,000
cash and cash equivalents at end of period	864,000	14,028,000		-372,000	5,356,000	11,372,000		1,085,000	-1,212,000	6,503,000		4,361,000	1,924,000	3,652,000		2,821,000	4,896,000	25,377,000		5,169,000	4,932,000	7,334,000		6,159,000	2,738,000	2,493,000		-827,000	-1,149,000	7,064,000		2,732,000	759,000	33,755,000		3,111,000	1,548,000	25,459,000		182,000	4,781,000	24,392,000		1,088,000	-2,660,000	34,620,000
loss on disposal of property, plant & equipment				0	-2,000	9,000
net income from consolidated operations
gain on sales of property, plant and equipment
gain on sale of molded fiber business											-28,000
distributions from equity method investment
prepaid expenses																					-669,000	-446,000	355,000	-392,000	-425,000	364,000	13,000	-113,000	610,000	-759,000	399,000	221,000	414,000	-588,000	-120,000	434,000	-169,000	-1,496,000
income taxes
additions to property, plant & equipment
acquisition of new businesses, net of cash acquired			-1,045,000
purchase of real estate			0
proceeds from sale of molded fiber											0
proceeds from the issuance of long-term debt																											0	0	0	20,000,000
payment of statutory withholding for restricted stock units vested
net change in cash and cash equivalents
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
proceeds from borrowings of long-term debt
acquisition of marble medical, net of cash acquired
other liabilities																																			8,000	93,000	-103,000	215,000
additions to property, plant and equipment																															-3,502,000	-2,409,000
proceeds from sale of property, plant and equipment
principal repayment of long-term debt
gain on disposal of property, plant & equipment								1,000	106,000	1,000		3,000	-6,197,000	-12,000
acquisition of advant, net of cash acquired												0	0	-20,768,000
acquisition of das medical, working capital adjustment												0	0	115,000
proceeds from exercise of stock options								0				346,000				0				-1,000	59,000	416,000
adjustments to reconcile net income to net cash provided by operating activities:
(gain) loss on sales of property, plant and equipment
interest expense on finance leases												1,000	2,000	1,000
refundable income taxes												-2,521,000			1,741,000	22,000			592,000	-780,000	199,000	284,000	1,757,000	-1,319,000	787,000	781,000	-1,319,000	-350,000	160,000	241,000	-38,000	-970,000	-9,000	807,000	-622,000	-1,000	543,000	289,000	-141,000	-429,000	2,136,000	796,000		807,000	-405,000	1,151,000
acquisition of contech medical, net of cash acquired
acquisition of das medical, net of cash acquired
principal payments on finance lease obligation																-2,000	-5,000	-4,000		-4,000
acquisition of dieletrics, net of cash acquired
loss on sale of fixed assets																				12,000
principal repayments of long-term debt																								-1,428,000				-714,000	-715,000	-714,000		-258,000	-258,000	-256,000		-253,000	-254,000	-251,000
gain on sale of fixed assets																						-4,000								-40,000		0	8,000	-5,000
proceeds from the exercise of stock options, net of shares presented for exercise
payment of statutory withholding for stock options exercised and restricted stock units vested
acquisition of dielectrics, net of cash acquired																												0	0	-76,978,000
proceeds from exercise of stock options, net of shares presented for exercise																								121,000	155,000	285,000		306,000	596,000	368,000
payment of statutory withholdings for stock options exercised and restricted stock units vested																								0	0	-271,000		0	0	-144,000		0	0	-107,000		0	-1,000	-88,000
net decrease in cash and cash equivalents																										-745,000											1,548,000	-4,345,000
excess tax benefits on share-based compensation
(gain) loss on sale of fixed assets																												4,000
adjustments to reconcile net income to net cash
provided by operating activities:
loss on sales of property, plant and equipment
repurchases of common stock
excess tax benefit on share-based compensation																																				0				0	36,000	183,000		11,000	271,000	563,000
proceeds from exercise of stock options, net of attestation																																315,000	236,000	79,000		80,000				0	92,000	128,000		13,000	242,000	81,000
proceeds from the exercise of stock options, net of attestations
payment of contingent note payable
changes in operating assets and liabilities, net of effects from acquisition:
holdback payment related to the acquisition of packaging alternatives corporation
redemption of cash value life insurance																																															191
proceeds from long-term borrowings
retirement and other liabilities																																										166,000
escrow deposit for texas building purchase
accrued taxes and other incomes
acquisition of pac net of cash acquired
distribution to united development company partners
proceds from sale of fixed assets
holdback payment related to the acquisition of packaging
alternatives corporation
gain on sales of property, plant, and equipment
stock issued in lieu of compensation
proceeds from sale of property, plant, and equipment
taxes receivable
distribution to united development company limited
acquisition of pac foam net of cash acquired
proceeds from the exercise of stock options net of attestations
gain on acquisitions
acquisition of foamade industries, inc.’s assets
acquisition of e.n. murray co. net of cash acquired
acquisition of advanced materials group assets
principal repayment of obligations under capital leases
restructuring charge—leasehold improvement write-off
equity in net income of unconsolidated affiliate and partnership
gain on disposal of property, plant, and equipment
acquisition of stephenson & lawyer net of cash acquired
payments received on affiliated partnership
proceeds from sale of common stock
net change in cash
cash settlements of restricted stock units
minority interest
(gain) or loss on disposal of property, plant and equipment
cash surrender value of officers’ life insurance
acquisition of assets of stephen packaging corp.
net borrowings (payments) under notes payable
tax benefit from exercise of non-qualified stock options
proceeds from refinancing capital leases
cash surrender value of officers life insurance
acquisition of assets of stephen packaging, corp.
change in book overdrafts
cash at beginning of year
cash at end of year
leasehold improvements
buildings and improvements
equipment
furniture and fixtures
loss on disposal of property, plant, and equipment
restructuring charges
refundable income tax
proceeds from surrender of officers life insurance
consolidation of united development company, net of cash
net borrowings under notes payable
loss on disposal of property, plant and equipment
acquisition of operating assets, less cash acquired
proceeds from disposal of property, plant and equipment
capital stock repurchase
significant non-cash transactions:
property and equipment acquired under capital lease
write-off of equipment against accrued restructuring charge
restructuring charge net of fixed assets write-off
(gain) loss on disposal of property, plant and equipment
cash surrender value of officers' life insurance
payments received on advances to affiliated partnership
net borrowings (repayments) under notes payable
restructuring charge
increase in other assets

We provide you with 20 years of cash flow statements for UFP Technologies stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of UFP Technologies stock. Explore the full financial landscape of UFP Technologies stock with our expertly curated income statements.

The information provided in this report about UFP Technologies stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.